Literature DB >> 1576279

Toxoplasmosis in pediatric recipients of heart transplants.

M G Michaels1, E R Wald, F J Fricker, P J del Nido, J Armitage.   

Abstract

Toxoplasma gondii has long been recognized as a potential cause of severe disease in the congenitally infected infant and the immunocompromised host. This report describes three children with toxoplasmosis after heart transplantation and reviews the cases of 18 adult recipients of cardiac transplants (reported in the English-language literature) who developed toxoplasmosis postoperatively. Onset of disease was within the first 6 1/2 months following transplantation. Severity ranged from asymptomatic seroconversion to myocardial infiltration or disseminated neurological disease and death. Only one patient was known to be seropositive for antibody to T. gondii prior to transplantation. Transmission was most likely via the donor organ. Seronegative patients who receive organs from seropositive donors are at high risk for serious disease; prophylactic strategies need to be developed.

Entities:  

Mesh:

Year:  1992        PMID: 1576279     DOI: 10.1093/clinids/14.4.847

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.

Authors:  Susan Keay
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 2.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

Review 3.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.

Authors:  Sandhya Kortagere; Ernest Mui; Rima McLeod; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2011-02-26       Impact factor: 3.686

Review 5.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

6.  Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.

Authors:  Solène Patrat-Delon; Jean-Pierre Gangneux; Sylvain Lavoué; Bernard Lelong; Claude Guiguen; Yves le Tulzo; Florence Robert-Gangneux
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

Review 7.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome.

Authors:  L E Leiva; J Junprasert; D Hollenbaugh; R U Sorensen
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

9.  A plasma membrane localized protein phosphatase in Toxoplasma gondii, PPM5C, regulates attachment to host cells.

Authors:  Chunlin Yang; Malgorzata Broncel; Caia Dominicus; Emily Sampson; William J Blakely; Moritz Treeck; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

10.  Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine.

Authors:  Tania Mara V Strabelli; Rinaldo Focaccia Siciliano; Silvia Vidal Campos; Jussara Bianchi Castelli; Fernando Bacal; Edimar A Bocchi; David E Uip
Journal:  J Trop Med       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.